Cancer Beats All Other Fields for New Drug Approvals in 2012
- Chemoprevention Strategies in Head and Neck Cancer
- Grading of Renal Cell Carcinoma
- Head and Neck Cancer - Resection and Neck Dissection
Eleven new drugs for the treatment of cancer were approved by the US Food and Drug Administration (FDA) in 2012 (so far). Only a few of these agents have been approved in Europe; most are still under review there.
"This is more than any other therapeutic category," Stephanie Yao, from the FDA Office of Public Affairs, told Medscape Medical News . So far this year, the FDA has approved 34 new molecular entities and new biologic agents this year, 11 of which were oncology drugs, she explained. And Yao pointed out that there are still 2 weeks left in this calendar year.
This is slightly more than last year, she said. In 2011, the FDA approved 30 new products, 8 of which were oncology drugs. That was also more than any other therapeutic category, she added.
(0)
(0)
